GLP-3 Retatrutide is a synthetic research peptide designed as a triple receptor agonist targeting the GLP-1, GIP, and glucagon receptors.

In preclinical studies, including diet-induced obese mice models, it has been associated with reductions in body weight along with improvements in insulin sensitivity, lipid profiles, and hepatic fat content.

This product is supplied strictly for research purposes only and is not intended for human or animal consumption or therapeutic use.